Zhaoyu Jin, Ph.D. - Publications

Affiliations: 
2005 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Pharmacology, Oncology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR, Ashkenazi A. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell. 137: 721-35. PMID 19427028 DOI: 10.1016/J.Cell.2009.03.015  0.447
2007 Ricci MS, Kim SH, Ogi K, Plastaras JP, Ling J, Wang W, Jin Z, Liu YY, Dicker DT, Chiao PJ, Flaherty KT, Smith CD, El-Deiry WS. Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death. Cancer Cell. 12: 66-80. PMID 17613437 DOI: 10.1016/J.Ccr.2007.05.006  0.704
2006 Jin Z, El-Deiry WS. Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis. Molecular and Cellular Biology. 26: 8136-48. PMID 16940186 DOI: 10.1128/Mcb.00257-06  0.634
2005 Dicker DT, Kim SH, Jin Z, El-Deiry WS. Heterogeneity in non-invasive detection of apoptosis among human tumor cell lines using annexin-V tagged with EGFP or Qdot-705. Cancer Biology & Therapy. 4: 1014-7. PMID 16222122 DOI: 10.4161/Cbt.4.9.2150  0.607
2005 Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biology & Therapy. 4: 139-63. PMID 15725726 DOI: 10.4161/Cbt.4.2.1508  0.591
2004 Ricci MS, Jin Z, Dews M, Yu D, Thomas-Tikhonenko A, Dicker DT, El-Deiry WS. Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Molecular and Cellular Biology. 24: 8541-55. PMID 15367674 DOI: 10.1128/Mcb.24.19.8541-8555.2004  0.689
2004 Jin Z, McDonald ER, Dicker DT, El-Deiry WS. Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. The Journal of Biological Chemistry. 279: 35829-39. PMID 15155747 DOI: 10.1074/Jbc.M405538200  0.67
2002 Jin Z, Dicker DT, El-Deiry WS. Enhanced sensitivity of G1 arrested human cancer cells suggests a novel therapeutic strategy using a combination of simvastatin and TRAIL. Cell Cycle (Georgetown, Tex.). 1: 82-9. PMID 12429913 DOI: 10.4161/Cc.1.1.104  0.591
2001 Goldberg GS, Jin Z, Ichikawa H, Naito A, Ohki M, El-Deiry WS, Tsuda H. Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis. Cancer Research. 61: 1334-7. PMID 11245430  0.615
2000 Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC, El-Deiry WS. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. Cancer Research. 60: 6318-25. PMID 11103792  0.553
1998 Tumang JR, Owyang A, Andjelic S, Jin Z, Hardy RR, Liou ML, Liou HC. c-Rel is essential for B lymphocyte survival and cell cycle progression. European Journal of Immunology. 28: 4299-312. PMID 9862367 DOI: 10.1002/(Sici)1521-4141(199812)28:12<4299::Aid-Immu4299>3.0.Co;2-Y  0.319
Show low-probability matches.